Latest News about FDA
Recent news which mentions FDA
Now That FDA Approved TG Therapeutics Multiple Sclerosis Treatment, Analyst Are Boosting Price Targets
December 29, 2022
Tickers
TGTX
From Benzinga
Abbott Launches the World’s Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
December 29, 2022
Tickers
ABT
China Relaxes Approval Of Imported Games, Google Workers Dread Mass Layoffs, FDA Working On Regulating Pathways For Cannabis: Today's Top Stories
December 28, 2022
From Benzinga
FDA Developing Regulating Pathways For Cannabis-Derived Ingredients In Foods, Supplements; Oversight Plans Expected In Few Months
December 28, 2022
From Benzinga
FDA Considers Regulating CBD In Foods & Supplements, Plans To Study Pregnancy And Daily Use
December 27, 2022
From Benzinga
Biogen's 2nd Alzheimer's Antibody, BeiGene's Cancer Drug Label Expansion, Adcom Test For Regeneron And More: January PDUFA Catalysts For Biotech Investors
December 27, 2022
From Benzinga
Roche's Follicular Lymphoma Therapy Scores FDA Approval
December 23, 2022
From Benzinga
DBV Technologies Shares Jumps As FDA Lifts Partial Hold On Pivotal Trial For Peanut Allergy Patch
December 23, 2022
Tickers
DBVT
From Benzinga
FDA Approves Gilead's New HIV Treatment For Heavily Treated With Multi-Drug Resistant Patients
December 22, 2022
Tickers
GILD
From Benzinga
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
From Benzinga
After Tests, Recalled DreamStation Sleep Devices Unlikely To Cause Harm, Philips Says
December 21, 2022
Tickers
PHG
From Benzinga
Magenta Therapeutics Shares Crashes As Dose-Limiting Toxicities Observed In Lead Blood Cancer Study
December 20, 2022
Tickers
MGTA
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.